Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Banchi

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancer Letters|April 18, 2024
Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedulesMarta Banchi, Maria Christina Cox, Guido Bocci
Medical Oncology (Northwood, London, England)|February 29, 2020
Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancerDaniela Gentile, Paola Orlandi, Marta Banchi, et al.
Journal of Clinical Medicine|November 11, 2022
Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical StudiesMarta Banchi, Elisabetta Fini, Stefania Crucitta, et al.
Current Oncology Reports|March 6, 2024
Metronomic Chemotherapy in Elderly PatientsArianna Bandini, Pasquale Fabio Calabrò, Marta Banchi, et al.
Chemotherapy|August 7, 2023
Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case ReportMarta Banchi, Tiziana Lanzolla, Arianna Di Napoli, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic ApproachPaola Orlandi, Anna Solini, Marta Banchi, et al.
Scientific Reports|April 2, 2025
Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathwayMarta Banchi, Maria Christina Cox, Paola Orlandi, et al.
Journal of Chemotherapy (Florence, Italy)|September 15, 2020
Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinomaPaola Orlandi, Marta Banchi, Greta Alì, et al.
American Journal of Cancer Research|August 11, 2020
Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancerMarta Banchi, Paola Orlandi, Daniela Gentile, et al.
Cancers|June 12, 2026
Prognostic Circulating Cytokine Panels for Metronomic Chemotherapy in Metastatic Gastrointestinal Cancer: Exploratory Pharmacodynamic Biomarker Analysis of the Phase II COMET TrialMaria Laura Manca, Paola Orlandi, Giacomo Allegrini, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Letters|April 18, 2024
Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedulesMarta Banchi, Maria Christina Cox, Guido Bocci
Medical Oncology (Northwood, London, England)|February 29, 2020
Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancerDaniela Gentile, Paola Orlandi, Marta Banchi, et al.
Journal of Clinical Medicine|November 11, 2022
Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical StudiesMarta Banchi, Elisabetta Fini, Stefania Crucitta, et al.
Current Oncology Reports|March 6, 2024
Metronomic Chemotherapy in Elderly PatientsArianna Bandini, Pasquale Fabio Calabrò, Marta Banchi, et al.
Chemotherapy|August 7, 2023
Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case ReportMarta Banchi, Tiziana Lanzolla, Arianna Di Napoli, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic ApproachPaola Orlandi, Anna Solini, Marta Banchi, et al.
Scientific Reports|April 2, 2025
Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathwayMarta Banchi, Maria Christina Cox, Paola Orlandi, et al.
Journal of Chemotherapy (Florence, Italy)|September 15, 2020
Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinomaPaola Orlandi, Marta Banchi, Greta Alì, et al.
American Journal of Cancer Research|August 11, 2020
Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancerMarta Banchi, Paola Orlandi, Daniela Gentile, et al.
Cancers|June 12, 2026
Prognostic Circulating Cytokine Panels for Metronomic Chemotherapy in Metastatic Gastrointestinal Cancer: Exploratory Pharmacodynamic Biomarker Analysis of the Phase II COMET TrialMaria Laura Manca, Paola Orlandi, Giacomo Allegrini, et al.
Pageof 3